B. Dixon

Most-cited papers

1. Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases

   B. Dixon, L. Greenbaum, Liwei Huang, S. Rajan +3 more

   2023Kidney International Reports93 citations Open access

   Semantic Scholar

   Save

2. Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children

   Amrit Kirpalani, N. Jawa, W. Smoyer, C. Licht +16 more

   2020Kidney International Reports28 citations Open access

   Semantic Scholar

   Save

3. Data mining in predicting survival of kidney dialysis patients

   Shital C. Shah, A. Kusiak, B. Dixon

   2003SPIE BiOS19 citations

   Semantic Scholar

   Save

4. POS-048 PHASE 3, RANDOMIZED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN TREATMENT OF C3G OR IC-MPGN

   G. Remuzzi, B. Dixon, F. Fakhouri, M. Pickering +9 more

   2022Kidney International Reports6 citations Open access

   Semantic Scholar

   Save

5. Corrigendum to PHASE 2 STUDY TO EVALUATE EFFICACY AND SAFETY OF PEGCETACOPLAN IN THE TREATMENT OF PATIENTS WITH POSTTRANSPLANT RECURRENCE OF C3G OR IC MPGN

   M. Pickering, B. Dixon, P. Walker, F. Fakhowri +5 more

   2022Kidney International Reports0 citations Open access

   Semantic Scholar

   Save

6. The Business School at Georgia Tech Dean's Report, 2006-2007

   Steven R. Salbu, H. Wilson, B. Dixon, Lee Thompson +1 more

   20070 citations

   Semantic Scholar

   Save